Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/18540
Title: Risk of myelotoxicity with intravenous cyclophosphamide in patients with systemic lupus erythematosus
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Adult,Cyclophosphamide/administration & dosage/*adverse effects,Female,Greece/epidemiology,Humans,Immunosuppressive Agents/administration & dosage/*adverse effects,Injections, Intravenous,Leukocyte Count,Lupus Erythematosus, Systemic/*complications/*drug therapy/epidemiology,Male,Neutropenia/*chemically induced/epidemiology,Platelet Count,Retrospective Studies,Risk Factors
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/18540
ISSN: 1462-0324
Link: http://www.ncbi.nlm.nih.gov/pubmed/12096228
http://rheumatology.oxfordjournals.org/content/41/7/780.full.pdf
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Katsifis-2002-Risk of myelotoxicit.pdf111.44 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons